Prolonged Survival With FK778 (Malononitrilamide) Monotherapy After Small Bowel Transplantation: A Large Animal Study
Authors:
- S. ZontaSZS. Zonta
- M. AlessianiMAM. Alessiani
- J. ViganòJVJ. Viganò
- M. DoniMDM. Doni
- M. BardoneMBM. Bardone
- T. DominioniTDT. Dominioni
- M. De MartinoMMM. De Martino
- M. ScaglioneMSM. Scaglione
- E. ViciniEVE. Vicini
- C. FilisettiCFC. Filisetti
- A. BiroliABA. Biroli
- A. BottazziABA. Bottazzi
- 1 July 2007
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 39 (6) , 2021-2023
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- FK778: New Cellular and Molecular Mechanisms of ActionTransplantation Proceedings, 2006
- Inhibition of Human Dendritic Cell Maturation and Function by the Novel Immunosuppressant FK778Transplantation, 2005
- Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts1 2Transplantation, 2003
- A schema for histologic grading of small intestine allograft acute rejectionTransplantation, 2003
- FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allograftsTransplantation, 2003
- Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates1Transplantation, 2003
- Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogsTransplantation, 2003
- A novel leflunomide derivative, FK778, for immunosuppression after kidney transplantation in dogsSurgery, 2002
- The Immunosuppressive Metabolite of Leflunomide Is a Potent Inhibitor of Human Dihydroorotate DehydrogenaseBiochemistry, 1996